We are finally getting what we asked for: Pharma is ponying up for head to head studies to provide us with meaningful data to help make better clinical decisions. However, these valuable projects are often with systemic agents, such as biologics, leaving topical treatments in the dust.
To address this, Dr. Lawrence Eichenfield, Professor of Dermatology and Pediatrics, UCSD, and colleagues sought to make the most out of the data we do have on the litany of topical options for atopic dermatitis and provide efficacy and safety guidance (A for effort!).
Tune in to hear what this dream team concocted about creams. Hear how an expert approaches new atopic dermatitis patients. Don’t miss out – this is all very topical.
Listen Now
You May Also Like
Sufficiently Insufficient to Support Steroid Stewardship
Sufficiently Insufficient to Support Steroid Stewardship
Guest: Dr. Rachel Sheskier Steroids: indispensable, unpredictable, and, when it comes to endocrinology, often hiding in plain sight. In this episode of the JDD Podcast, Dr. Adam Friedman continues the…
Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology
Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology
Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology Guest: Dr. Sumayya Ahmad Steroids: beloved (maybe), feared (yup), and, when it comes to the eye, handled with just…
Inhaled, Applied, Prescribed: Steroids Through the Allergy Lens
Inhaled, Applied, Prescribed: Steroids Through the Allergy Lens
Inhaled, Applied, Prescribed: Steroids Through the Allergy Lens Guest: Dr. Bob Geng We all reach for corticosteroids—whether it's that trusty tube, inhaler, or systemic burst (or maybe all of the…
